Westside Investment Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Westside Investment Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-666	Closed	-$113	–	871
2022 Q3	$113	Sell	666 -9,334	-93%	-$8.62K	﹤0.01%	350
2022 Q2	$2.97K	Buy	10,000 +9,333	+1,399%	+$15.4K	0.01%	229
2022 Q1	$2.97K	Hold	667	–	–	0.01%	230
2021 Q4	$7.23K	Hold	667	–	–	0.02%	196
2021 Q3	$7.23K	Hold	667	–	–	0.02%	197
2021 Q2	$11.3K	Buy	+667	New	+$12.6K	0.03%	177
2021 Q1	–	Sell	-4	Closed	-$137	–	760
2020 Q4	$137	Hold	4	–	–	﹤0.01%	271
2020 Q3	$134	Hold	4	–	–	﹤0.01%	280
2020 Q2	$161	Buy	+4	New	+$270	﹤0.01%	246

Westside Investment Management's EVFM Position: Q4 2022 in Review

Westside Investment Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2022, closing a stake of 666 shares — an estimated $113 sold.

Westside Investment Management first reported a position in EVFM in Q2 2020 and held it in 9 quarters. The position peaked at $11.3K in Q2 2021. 0 funds tracked by Wall St. Rank hold EVFM as of Q4 2022.

Westside Investment Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Westside Investment Management sold 666 Evofem Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $113.
Westside Investment Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
Westside Investment Management's Evofem Biosciences, Inc. Common Stock position peaked at $11.3K in Q2 2021.
0 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2022.

Based on Westside Investment Management's 13F filing for Q4 2022, filed 31 Jan 2023.